The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index; 4 of the 19 sources its claims cite were checked for support.
Epinephrine-induced Insulin Resistance in Man
Open accessAbstract
Endogenous release of epinephrine after stress as well as exogenous epinephrine infusion are known to result in impaired glucose tolerance. Previous studies of man and animals have demonstrated that this effect of epinephrine results from inhibition of insulin secretion and augmentation of hepatic glucose production. However, the effect of epinephrine on tissue sensitivity to insulin, and the relative contributions of peripheral vs. hepatic resistance to impaired insulin action, have not been defined. Nine young normal-weight subjects were studied with the insulin clamp technique. Plasma insulin was raised by approximately 100 muU/ml while plasma glucose concentration was maintained at basal levels by a variable glucose infusion. Under these conditions of euglycemia, the amount of glucose metabolized equals the glucose infusion rate and is a measure of tissue sensitivity to insulin. Subjects received four studies: (a) insulin (42.6 mU/m(2).min), (b) insulin plus epinephrine (0.05 mug/kg.min), (c) insulin plus epinephrine plus propranolol (1.43 mug/kg.min), and (d) insulin plus propranolol. During insulin administration alone, glucose metabolism averaged 5.49+/-0.58 mg/kg.min. When epinephrine was infused with insulin, glucose metabolism fell by 41% to 3.26 mg/kg.min (P < 0.001). After insulin alone, hepatic glucose production declined by 92% to 0.16+/-0.08 mg/kg.min. Addition of epinephrine was associated with a delayed and incomplete suppression of glucose production (P < 0.01) despite plasma insulin levels >100 muU/ml. When propranolol was administered with epinephrine, total glucose metabolism was restored to control values and hepatic glucose production suppressed normally. Propranolol alone had no effect on insulin-mediated glucose metabolism. These results indicate that epinephrine, acting primarily through a beta-adrenergic receptor, markedly impairs tissue sensitivity to an increase in plasma insulin levels, and that this effect results from both peripheral and hepatic resistance to the action of insulin.
Overview
CoChat Summary
TL;DR
In nine healthy young adults, epinephrine infusion during euglycemic hyperinsulinemia reduced insulin-mediated glucose metabolism by 41% and blunted insulin suppression of hepatic glucose production. Propranolol reversed both effects, indicating that epinephrine-induced insulin resistance is mediated primarily through β-adrenergic receptors and involves peripheral and hepatic tissues.
Key findings
- During insulin clamp alone, total glucose metabolism averaged 5.49±0.58 mg/kg·min; adding epinephrine (0.05 μg/kg·min) reduced it by 41% to 3.26±0.24 mg/kg·min (P < 0.001).
- Insulin alone suppressed endogenous glucose production by 92% to 0.16±0.08 mg/kg·min; epinephrine caused delayed and incomplete suppression (60–120 min: 0.73±0.18 vs. 0.16±0.08 mg/kg·min; P < 0.005), and during the first 20 min hepatic glucose production rose to 2.58±0.32 vs. 0.49±0.16 mg/kg·min.
- Propranolol with epinephrine restored total glucose metabolism to 5.73±0.67 mg/kg·min, not significantly different from control, and blocked epinephrine’s hepatic effect; propranolol alone had no significant effect (5.28±0.42 mg/kg·min).
- Epinephrine also potentiated the insulin-induced decline in all plasma amino acids except alanine by ~15–20% greater than insulin alone; propranolol reversed this effect.
Methods
- Design: euglycemic insulin clamp with [3-3H]glucose in nine healthy volunteers (five females, four males; age 23–30 yr, mean 26±1 yr; 90–112% ideal body weight, mean 99±2%), each serving as their own control, studied postabsorptive after a 12-h overnight fast.
- Four protocols: insulin alone (42.6 mU/m²·min), insulin plus epinephrine (0.05 μg/kg·min), insulin plus epinephrine plus propranolol, and insulin plus propranolol; plasma glucose was maintained at basal levels while plasma insulin was raised to steady-state ~132–135 μU/ml.
- Analysis: under steady-state euglycemia, glucose infusion rate equals tissue sensitivity to insulin; endogenous glucose production was calculated using tritiated glucose; data are mean±SEM with paired Student’s t tests.
Limitations
- Stated: smaller epinephrine doses, as might be expected in mild to moderate stress, were not examined; no α-adrenergic blocker was administered, so a contribution of α-adrenergic receptors to insulin antagonism cannot be excluded.
- Evident from the text: the sample was small (n=9), young, healthy, and normal-weight, and the clamp period was 2 h; propranolol co-infusion raised plasma epinephrine to 1,441±96 vs. 736±23 pg/ml with epinephrine alone, though the authors state this does not alter interpretation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
2 Valid · 1 Not valid · 4 Not checked · 28 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“an in vivo effect of epinephrine on peripheral glucose metabolism independent of changes in plasma insulin levels has not been conclusively documnented.”
What the sources say
- Not checked — no full text of the sourcecites [1] 1. Sacca, L., R. Sherwin, and P. Felig. 1978. Effect of sequential infusions of glucagon and epinephrine on glucose turnover in the dog. Am. J. Physiol. 235(3): E287-E290. source
- Disputedcites [2] 2. Eigler, N., L. Sacca, and R. Sherwin. 1979. Synergistic interactions of physiological increments of glucagon, epinephrine, and cortisol in the dog. J. Clin. Invest. 63: 114-123. sourceExperimental — accuracy not yet measured
The Discussion reports that epinephrine reduced glucose clearance in conscious dogs despite a two- to fourfold rise in plasma insulin, and concludes that the effect was not mediated primarily by suppressed insulin secretion. This is contrary to the claim that an in vivo peripheral effect had not been documented independently of changes in insulin levels, although the paper does not claim to have excluded every contribution from insulin secretion. (LLM, conf=0.78)
Checked by a reasoning model — may be wrong.
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Several studies have documented that epinephrine inhibits insulin secretion (1–5)”
What the sources say
- Not checked — no full text of the sourcecites [1] 1. Sacca, L., R. Sherwin, and P. Felig. 1978. Effect of sequential infusions of glucagon and epinephrine on glucose turnover in the dog. Am. J. Physiol. 235(3): E287-E290. source
- Partly supportedcites [2] 2. Eigler, N., L. Sacca, and R. Sherwin. 1979. Synergistic interactions of physiological increments of glucagon, epinephrine, and cortisol in the dog. J. Clin. Invest. 63: 114-123. sourceExperimental — accuracy not yet measured
On p. 120, the paper says epinephrine subsequently inhibits insulin release in dogs. It also reports an initial twofold rise in plasma insulin and describes the effect as biphasic, so the unqualified claim omits an important timing qualification. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [3] 3. Altszuler, N., R. Steele, I. Rathgeb, and R. C. DeBodo. 1967. Glucose metabolism and plasma insulin levels during epinephrine infusion in the dog. Am. J. Physiol. 212(3): 677–682. source
- Supportedcites [4] 4. Coore, H. G., and P. J. Randle. 1964. Regulation of insulin secretion studied with pieces of rabbit pancreas incubated in vitro. Biochem. J. 93: 66–78. source
The Results report that adrenaline (epinephrine) abolished the stimulation of insulin release by high glucose in rabbit pancreas pieces incubated in vitro. The Discussion identifies this inhibitory effect as a major finding. The paper also notes that adrenaline had no effect at low glucose; the citing sentence does not claim inhibition under every condition. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [5] 5. Porte, D. 1967. A receptor mechanism for the inhibition of insulin release by epinephrine in man. J. Clin. Invest. 46: 86–94. source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“During both clamp studies in which propranolol was infused, the decline in plasma glucagon was similar to the control insulin clamp study (P < 0.05).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“After insulin alone, hepatic glucose production declined by 92% to 0.16±0.08 mg/kg·min.”
plainstates a causen = 9- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“During insulin administration alone, glucose metabolism averaged 5.49±0.58 mg/kg·min.”
plainn = 9- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
16 more claims
Create a free account to see all 35 claims and every source verdict.
- It may state two separate claims as one. 9
- Probably not a substantial claim. 7
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased sympathovagal balance also adds to insulin resistance131”
From Interacting epidemics? Sleep curtailment, insulin resistance, and obesity (2012) · cites this paper as [131]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
Cited work 10.1210/jcem-50-2-294 · retracted 1980-11-01 · notice 10.1210/jcem-51-5-1201 · this paper published 1980-03-01
Citations
Cites
1 retracted
Soman, V., Shamoon, H., Sherwin, R. S., & Ziegler, W. H. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-2-294 · Cited by 22
RetractedGlucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Self-citationRegulation of insulin secretion studied with pieces of rabbit pancreas incubated in vitro
Coore, H., & Randle, P. (1964) · Biochemical Journal · doi:10.1042/bj0930066 · Cited by 540
EFFECT OF EPINEPHRINE ON RAT DIAPHRAGM
Walaas, O., & Walaas, E. (1950) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)56223-2 · Cited by 410
A Receptor Mechanism for the Inhibition Of Insulin Release by Epinephrine in Man*
Porte, D. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105514 · Cited by 398
Exton, J. H., Robison, G. A., Sutherland, E. W., & Park, C. R. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61771-5 · Cited by 320
DeFronzo, R. A., Ferrannini, E., Hendler, R., Wahren, J., & Felig, P. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.10.5173 · Cited by 296
Self-citationChristensen, N. J. (1974) · Diabetes · doi:10.2337/diab.23.1.1 · Cited by 287
Mechanism of Plasma Catecholamine Increases During Surgical Stress in Man
HALTER, J. B., PFLUG, A. E., & PORTE, D. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-45-5-936 · Cited by 279
Control of Gluconeogenesis in Liver
Exton, J. H., & Park, C. R. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93242-4 · Cited by 278
Cited by
Aune, D., Giovannucci, E., Boffetta, P., Fadnes, L. T., Keum, N., Norat, T., Greenwood, D. C., Riboli, E., Vatten, L. J., & Tonstad, S. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyw319 · Cited by 2,419
The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension
Kaplan, N. M. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.7.1514 · Cited by 1,516
Assessment of Insulin Sensitivity in Vivo*
Bergman, R. N., Finegood, D. T., & Ader, M. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-1-45 · Cited by 1,066
Copps, K. D., & White, M. F. (2012) · Diabetologia · doi:10.1007/s00125-012-2644-8 · Cited by 1,017
“The correlation between excessive β-adrenergic activity and insulin resistance has long been noted [131].”
BackgroundGiovannucci, E. (1995) · Cancer Causes and Control · doi:10.1007/bf00052777 · Cited by 817
Effects of Sleep Fragmentation on Glucose Metabolism in Normal Subjects
Stamatakis, K. A., & Punjabi, N. M. (2010) · Chest · doi:10.1378/chest.09-0791 · Cited by 614
Insulin Resistance in Chronic Heart Failure: Relation to Severity and Etiology of Heart Failure
Swan, J. W., Anker, S. D., Walton, C., Godsland, I. F., Clark, A. L., Leyva, F., Stevenson, J. C., & Coats, A. J. S. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00185-x · Cited by 533
“However, some studies (14,15) have implicated increased catecholamine levels as a cause of insulin resistance (and hyperinsulinemia) in patients without heart disease, indicating that a disturbance of the normal feedback mechanism may occur in insulin-resistant states.”
BackgroundHeart rate and the cardiovascular risk
Palatini, P., & Julius, S. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715010-00001 · Cited by 505
Physiopharmacological interactions between stress hormones and central serotonergic systems
Chaouloff, F. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90005-k · Cited by 493
The selfish brain: Competition for energy resources
Peters, A., Schweiger, U., Pellerin, L., Hubold, C., Oltmanns, K. M., Conrad, M., Schultes, B., Born, J., & Fehm, H. L. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.03.002 · Cited by 489
Heart Rate Variability in Insomniacs and Matched Normal Sleepers
Bonnet, M. H., & Arand, D. L. (1998) · Psychosomatic Medicine · doi:10.1097/00006842-199809000-00017 · Cited by 454
“For example, hypertension, elevated plasma insulin (34) and its related decrease in HDL cholesterol, increase in triglyceride and cholesterol (35), increased hematocrit (36), decreased plasma volume (37), increased plasma thromboglobulin (38), increased plasma angiotensin (39), and increased cardiac arrhythmias (40, 4…”
BackgroundFasting glucose is a risk factor for breast cancer: a prospective study.
Muti, P. C., Quattrin, T., Grant, B. J. B., Krogh, V., Micheli, A., Schünemann, H. J., Ram, M., Freudenheim, J. L., Sieri, S., Trevisan, M., et al. (2002) · PubMed · Cited by 396
Caffeine Can Decrease Insulin Sensitivity in Humans
Keijzers, G. B., De Galan, B. E., Tack, C. J., & Smits, P. (2002) · Diabetes Care · doi:10.2337/diacare.25.2.364 · Cited by 358
“Using the euglycemic clamp technique, Deibert and DeFronzo (9) showed that epinephrine infusion reduced tissue sensitivity to insulin by 50%.”
Castellino, P., Luzi, L., Simonson, D. C., Haymond, M., & DeFronzo, R. A. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113272 · Cited by 344
Self-citationEffects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers.
Louis, M., & Punjabi, N. M. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.91523.2008 · Cited by 342
“Indeed, administration of epinephrine to healthy volunteers decreases glycogenesis, increases glycolysis, and diminishes the ability of glucose to stimulate its own disposal (13, 23).”
BackgroundAdrenergic Mechanisms for the Effects of Epinephrine on Glucose Production and Clearance in Man
Rizza, R. A., Cryer, P. E., Haymond, M. W., & Gerich, J. E. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109714 · Cited by 340
Reflex sympathetic activation induces acute insulin resistance in the human forearm.
Jamerson, K. A., Julius, S., Gudbrandsson, T., Andersson, O., & Brant, D. O. (1993) · Hypertension · doi:10.1161/01.hyp.21.5.618 · Cited by 311
“Epinephrine causes hyperglycemia and decreases the insulin-mediated glucose uptake in skeletal muscle cells.(24)-(25) During glucose clamp studies Deibert and DeFronzo(24) infused epinephrine to reproduce plasma epinephrine levels similar to the ones observed during stress and in diabetic ketoacidosis.”
BackgroundThe impact of sleep disorders on glucose metabolism: endocrine and molecular mechanisms
Briançon-Marjollet, A., Weiszenstein, M., Henri, M., Thomas, A., Godin-Ribuot, D., & Polak, J. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0018-3 · Cited by 311
“Adrenal epinephrine released during sympathetic activation triggers glucose production and impairs insulin secretion, thereby promoting insulin resistance [290].”
BackgroundAlterations in Glucose Disposal in Sleep-disordered Breathing
Punjabi, N. M., & Beamer, B. A. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200809-1392oc · Cited by 305
Bangalore, S., Parkar, S., Grossman, E., & Messerli, F. H. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.05.057 · Cited by 290
Insulin–PI3K signalling: an evolutionarily insulated metabolic driver of cancer
Hopkins, B. D., Goncalves, M. D., & Cantley, L. C. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0329-9 · Cited by 288
Aune, D., Sen, A., ó'Hartaigh, B., Janszky, I., Romundstad, P. R., Tonstad, S., & Vatten, L. J. (2017) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.04.004 · Cited by 284
Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus
Epstein, F. H., Cryer, P. E., & Gerich, J. E. (1985) · New England Journal of Medicine · doi:10.1056/nejm198507253130405 · Cited by 273
High Heart Rate: A Risk Factor for Cardiovascular Death in Elderly Men
Palatini, P., Casiglia, E., Julius, S., & Pessina, A. C. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.6.585 · Cited by 270
“The abnormal sympathetic tone, in turn, may cause the metabolic complex of insulin resistance, hyperglycemia, and hypertriglyceridemia, as demonstrated by numerous studies.(22-28) In elderly subjects, the pathogenesis of the connection between elevated heart rate and cardiovascular mortality might be also a low level…”
BackgroundNew concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus
Defronzo, R. A., Ferrannini, E., & Koivisto, V. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90654-x · Cited by 262
Self-citationAutonomic imbalance, hypertension, and cardiovascular risk
BROOK, R. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)00228-4 · Cited by 257
“This was demonstrated by euglycemic hyperinsulinemic clamp to be a process that occurs acutely and is reversible with β-blockers”
BackgroundLembo, G., Napoli, R., Capaldo, B., Rendina, V, Iaccarino, G., Volpe, M., Trimarco, B., & Saccà, L. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115842 · Cited by 252
HORMONAL CONTROL OF METABOLISM IN TRAUMA AND SEPSIS
Frayn, K. N. (1986) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1986.tb03288.x · Cited by 243
Rand, J. S., Kinnaird, E., Baglioni, A., Blackshaw, J., & Priest, J. (2002) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2002.tb02343.x · Cited by 241
Houseknecht, K. L., Robertson, A. S., Zavadoski, W., Gibbs, E. M., Johnson, D. E., & Rollema, H. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301209 · Cited by 240
“Similarly, epinephrine-induced insulin resistance has been observed in humans (Deibert and DeFronzo, 1980).”
BackgroundSympathetic overactivity in hypertension. A moving target
JULIUS, S., & NESBITT, S. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(96)00287-7 · Cited by 237
Inflammation in sleep apnea: An update
Unnikrishnan, D., Jun, J., & Polotsky, V. (2015) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9304-x · Cited by 227
Guelfi, K. J., Jones, T. W., & Fournier, P. A. (2005) · Diabetes Care · doi:10.2337/diacare.28.6.1289 · Cited by 219
“In addition, the increase in catecholamine levels in response to IHE would likely stimulate increased hepatic glucose production (25) and at the same time inhibit insulin-mediated glucose uptake (26).”
BackgroundCorcoran Lecture. Sympathetic hyperactivity and coronary risk in hypertension.
Julius, S. (1993) · Hypertension · doi:10.1161/01.hyp.21.6.886 · Cited by 215
Thermic effect of glucose in man. Obligatory and facultative thermogenesis.
Acheson, K. J., Ravussin, E., Wahren, J., & Jéquier, E. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111573 · Cited by 209
Insulin resistance after abdominal surgery
Thorell, A., Efendic, S., Gutniak, M., Häggmark, T., & Ljungqvist, O. (1994) · Journal of British Surgery · doi:10.1002/bjs.1800810120 · Cited by 206
The role of cardiac autonomic function in hypertension and cardiovascular disease
Palatini, P., & Julius, S. (2009) · Current Hypertension Reports · doi:10.1007/s11906-009-0035-4 · Cited by 195
“Acute infusion of adrenaline in human volunteers causes acute insulin resistance, which can be blocked with propranolol [ 33 ].”
BackgroundInteracting epidemics? Sleep curtailment, insulin resistance, and obesity
Lucassen, E. A., Rother, K. I., & Cizza, G. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06655.x · Cited by 191
Cardiac Troponin I in Feline Hypertrophic Cardiomyopathy
Herndon, W. E., Kittleson, M. D., Sanderson, K., Drobatz, K. J., Clifford, C. A., Gelzer, A. R., Summerfield, N. J., Linde, A., & Sleeper, M. M. (2002) · Journal of Veterinary Internal Medicine · doi:10.1892/0891-6640(2002)016 · Cited by 118
Inhibitory Effect of Epinephrine on Insulin-stimulated Glucose Uptake by Rat Skeletal Muscle
Chiasson, J.-L., Shikama, H., Chu, D. T. W., & Exton, J. H. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110306 · Cited by 178
Antihypertensive Therapy and Incidence of Type 2 Diabetes
Padwal, R., & Laupacis, A. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.247 · Cited by 173
Influence of beta-adrenergic blockade on glucose-induced thermogenesis in man.
Acheson, K., Jéquier, E., & Wahren, J. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111070 · Cited by 171
Fasting Plasma Free Fatty Acids and Risk of Type 2 Diabetes
Pankow, J. S., Duncan, B. B., Schmidt, M. I., Ballantyne, C. M., Couper, D. J., Hoogeveen, R. C., & Golden, S. H. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.77 · Cited by 166
“Catecholamines may induce insulin resistance (36), but it is unclear whether this is mediated by FFAs.”
BackgroundPalatini, P., Casiglia, E., Pauletto, P., Staessen, J., Kaciroti, N., & Julius, S. (1997) · Hypertension · doi:10.1161/01.hyp.30.5.1267 · Cited by 165
Ryan, S. (2017) · The Journal of Physiology · doi:10.1113/jp273312 · Cited by 159
“The Journal of Physiology C© 2016 The Physiological Society as catecholamines are known to decrease insulin sensitivity, to reduce insulin-mediated glucose uptake and to stimulate hepatic gluconeogenesis (Deibert & DeFronzo, 1980; Dungan et al. 2009).”
BackgroundDiabetes as a marker of pheochromocytoma in hypertensive patients
Batide-Alanore, A. L., Châtellier, G., & Plouin, P. (2003) · Journal of Hypertension · doi:10.1097/00004872-200309000-00020 · Cited by 157
Jansson, T., & Lambert, G. W. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917090-00002 · Cited by 166
The Interconnection between Sympathetics, Microcirculation, and Insulin Resistance in Hypertension
Julius, S., Gudbrandsson, T., Jamerson, K., & Andersson, O. (1992) · Blood Pressure · doi:10.3109/08037059209065119 · Cited by 154
Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis.
Petrides, A. S., Groop, P., Riely, C. A., & DeFronzo, R. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115340 · Cited by 150
Self-citationEssential hypertension, metabolic disorders, and insulin resistance
Ferrannini, E., & Natali, A. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90433-i · Cited by 163
Effect of Calcium Antagonists on Plasma Norepinephrine Levels, Heart Rate, and Blood Pressure
Grossman, E., & Messerli, F. H. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00722-4 · Cited by 145
(2000) · PubMed · Cited by 146
Shigetoh, Y., Adachi, H., Yamagishi, S., Enomoto, M., Fukami, A., Otsuka, M., Kumagae, S., Furuki, K., Nanjo, Y., & Imaizumi, T. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2008.331 · Cited by 148
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Ayala, J. E., Bracy, D. P., Malabanan, C. M., James, F. D., Ansari, T., Fueger, P. T., McGuinness, O. P., & Wasserman, D. H. (2011) · Journal of Visualized Experiments · doi:10.3791/3188 · Cited by 157
Tverdal, A., Hjellvik, V., & Selmer, R. M. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn435 · Cited by 150
“It is known that long-term sympathetic over-activity can produce a state of insulin resistance.(13,14) A recent study on non-diabetic subjects concluded that hypertriglyceridemia, low HDL-cholesterol, and hyperuricemia seemed to be particularly linked with both hyperinsulinemia and insulin resistance.”
BackgroundImprovement of Insulin Sensitivity after Adrenalectomy in Patients with Pheochromocytoma
Wiesner, T., Blüher, M., Windgassen, М., & Paschke, R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030000 · Cited by 148
Bønaa, K. H., & Arnesen, E. (1992) · Circulation · doi:10.1161/01.cir.86.2.394 · Cited by 142
Insulin resistance and sympathetic overactivity in women
Kaaja, R., & Pöyhönen‐Alho, M. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000194121.19851.e5 · Cited by 148
Smith, U., Kuroda, M., & Simpson, I. A. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)47218-8 · Cited by 140
Acute noradrenergic activation induces insulin resistance in human skeletal muscle
Lembo, G., Capaldo, B., Rendina, V., Iaccarino, G., Napoli, R., Guida, R., Trimarco, B., & Sacca, L. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.266.2.e242 · Cited by 136
James, D. E., Burleigh, K. M., & Kraegen, E. W. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84571-4 · Cited by 136
Battram, D. S., Arthur, R., Weekes, A., & Graham, T. E. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.5.1276 · Cited by 135
Glucose metabolism in cirrhosis: A review with some perspectives for the future
Petrides, A. S., & DeFronzo, R. A. (1989) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610050805 · Cited by 128
Self-citationCollins, J. W., Hoppe, M., Brown, K. S., et al. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)82212-7 · Cited by 132
Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoea.
Kent, B. D., McNicholas, W. T., & Ryan, S. (2015) · PubMed · doi:10.3978/j.issn.2072-1439.2015.08.11 · Cited by 155
“There is also compelling evidence for a role of sympathetic activation—which negatively affects insulin secretion and sensitivity (71,72)—in response to sleep deprivation and fragmentation, reflected in an increase in blood pressure, lower heart rate variability and decreased baroreflex sensitivity (58,73).”
BackgroundEpinephrine and potassium homeostasis
DeFronzo, R. A., DeFronzo, R. A., BIA, M. J., et al. (1981) · Kidney International · doi:10.1038/ki.1981.108 · Cited by 125
Self-citationThe Source of Glycolytic Intermediates in Mammalian Tissues
TeSlaa, T. A., Bartman, C., Jankowski, C. S. R., Zhang, Z., Xu, X., Xing, X., Wang, L., Lu, W., Hui, S. T., & Rabinowitz, J. D. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.12.020 · Cited by 124
“Glycogen breakdown, or glycogenolysis, can be stimulated by epinephrine (Deibert and Defronzo, 1980; Sutherland and Wosilait, 1956).”
BackgroundThong, F. S. L., & Graham, T. E. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01229.2001 · Cited by 122
“A large body of evidence indicates that elevated epinephrine levels acting via -adrenergic receptors selectively induce whole body insulin resistance by transiently increasing hepatic glucose production and impairing glucose clearance by skeletal muscle (2, 3, 8, 17, 22).”
Role of Elevated Heart Rate in the Development of Cardiovascular Disease in Hypertension
Palatini, P. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.173104 · Cited by 142
Exercise and Glycemic Control in Diabetes: Benefits, Challenges, and Adjustments to Pharmacotherapy
Gulve, E. A. (2008) · Physical Therapy · doi:10.2522/ptj.20080114 · Cited by 120
Obstructive sleep apnea as a risk factor for type 2 diabetes mellitus
Greenberg, H. E., & Rajan, P. (2015) · Nature and Science of Sleep · doi:10.2147/nss.s90835 · Cited by 137
Effect of epinephrine on glucose metabolism in humans: contribution of the liver
Sherwin, R. S., & Saccà, L. (1984) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1984.247.2.e157 · Cited by 122
Islet function and stress hyperglycemia: plasma glucose and epinephrine interaction
Halter, J. B., Beard, J. C., & Porte, D. (1984) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1984.247.1.e47 · Cited by 118
Pregnancy-induced insulin resistance in the rat: assessment by glucose clamp technique
Leturque, A., Burnol, A., Ferré, P., & Girard, J. R. (1984) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1984.246.1.e25 · Cited by 116
Effect of beta and alpha adrenergic blockade on glucose-induced thermogenesis in man.
DeFronzo, R. A., Thorin, D., Felber, J. P., Simonson, D. C., Thiébaud, D., Jéquier, E., & Golay, A. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111253 · Cited by 118
Self-citationRelease and Clearance Rates of Epinephrine in Man: Importance of Arterial Measurements*
Best, J. D., & Halter, J. B. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-2-263 · Cited by 115
The severity of obstructive sleep apnoea is associated with insulin resistance
Tiihonen, M., Partinen, M., & Närvänen, S. (1993) · Journal of Sleep Research · doi:10.1111/j.1365-2869.1993.tb00062.x · Cited by 113
Lee, S., HUDSON, R. W., Kilpatrick, K., Graham, T. E., & Ross, R. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.566 · Cited by 133
“Some (19,20) suggest that caffeine antagonizes skeletal muscle adenosine receptors, whereas others (6,7,21) suggest that caffeine results in a significant increase in epinephrine, with the latter inhibiting the ability of insulin to stimulate peripheral glucose uptake and suppress hepatic glucose production (22,23).”
BackgroundBarsheshet, A., Garty, M., Grossman, E., Sandach, A., Lewis, B. S., Gottlieb, S., Shotan, A., Behar, S., Caspi, A., Schwartz, R., et al. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.15.1613 · Cited by 120
“Activation of the sympathetic system not only increases insulin resistance but also decreases the release of insulin from the pancreatic beta cells and increases hepatic glucose production by stimulating both gluconeogenesis and glycogenolysis.(18,19) However, hyperglycemia may contribute to exacerbation of HF by seve…”
BackgroundAngiotensin II induces insulin resistance independent of changes in interstitial insulin
Richey, J. M., Ader, M., Moore, D., & Bergman, R. N. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.5.e920 · Cited by 103
Metabolic Consequences of Sleep-Disordered Breathing
Jun, J. C., & Polotsky, V. Y. (2009) · ILAR Journal · doi:10.1093/ilar.50.3.289 · Cited by 112
Song, S. O., He, K., Narla, R. R., Kang, H. G., Ryu, H. U., & Boyko, E. J. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0256 · Cited by 122
Phosphorylation of Purified Insulin Receptor by cAMP Kinase
Roth, R. A., & Beaudoin, J. D. (1987) · Diabetes · doi:10.2337/diab.36.1.123 · Cited by 106
“The decrease in receptor kinase activity would explain the ability of catecholamines to induce insulin resistance in isolated adipocytes (6,7) and in vivo (8).”
BackgroundLuzi, L., Secchi, A., Facchini, F., Battezzati, A., Staudacher, C., Spotti, D., Castoldi, R., Ferrari, G. C., Carlo, V. D., & Pozza, G. (1990) · Diabetologia · doi:10.1007/bf00404143 · Cited by 101
The roles of insulin and hyperglycemia in sepsis pathogenesis
Andersen, S. K., Gjedsted, J., Christiansen, C. F., & Tønnesen, E. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0503195 · Cited by 114
“Peripherally, epinephrine and -adrenergic stimulation rapidly inhibit insulin-mediated glucose uptake (IMGU) by induction of insulin resistance, mainly in the skeletal muscle [35].”
BackgroundIn vivo glucose metabolism in the awake rat: Tracer and insulin clamp studies
Smith, D., Rossetti, L., Ferrannini, E., Johnson, C. M., Cobelli, C., TOFFOLO, G. M., Katz, L. D., & DeFronzo, R. A. (1987) · Metabolism · doi:10.1016/0026-0495(87)90244-7 · Cited by 99
Self-citationCaptopril and Insulin Sensitivity
Ferrière, M., LACHKAR, H., Richard, J.-L., Bringer, J., ORSETTI, A., & MIROUZE, J. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-1-134_3 · Cited by 100
Clark, A. L., Coats, A. J. S., Krum, H., Katus, H. A., Mohaçsi, P., Salekin, D., Schultz, M. K., Packer, M., & Anker, S. D. (2017) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12191 · Cited by 99
“Blockade of β2-receptors seems to have a more profound effect than blockade of β1-receptors.(5,18) In addition, sympathetic activation can decrease the secretion of leptin,(17) exacerbate insulin resistance,(18) and promote the release of proinflammatory cytokines,(19) all of which can lead to wasting of adipose and m…”
Acute impairment of regional myocardial glucose uptake in the apical ballooning (takotsubo) syndrome
Bybee, K. A., Murphy, J. G., Prasad, A., et al. (2006) · Journal of Nuclear Cardiology · doi:10.1007/bf02971249 · Cited by 98
Kawaguchi, T., Nagao, Y., Matsuoka, H., Ide, T., & Sata, M. (2008) · International Journal of Molecular Medicine · doi:10.3892/ijmm.22.1.105 · Cited by 106
Purdon, C., Brousson, M., Nyveen, S. L., Miles, P. D. G., Halter, J. B., Vranić, M., & Marliss, E. B. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.3.8445012 · Cited by 110
Clonidine Prevents Insulin Resistance and Hypertension in Obese Dogs
Rocchini, A. P., Mao, H. Z., Babu, K., Marker, P. H., & Rocchini, A. J. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.548 · Cited by 99
ZeGlobalTox: An Innovative Approach to Address Organ Drug Toxicity Using Zebrafish
Cornet, C., Calzolari, S., Prieto, R. M., Dyballa, S., van Doornmalen, E. J. P., Rutjes, H., Savy, T., D’Amico, D., & Terriente, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040864 · Cited by 97
“Furthermore, (±)-epinephrine stimulates the breakdown of glycogen in the liver releasing glucose [67].”
BackgroundCaffeine Impairs Glucose Metabolism in Type 2 Diabetes
Lane, J. D., Barkauskas, C. E., Surwit, R. S., & Feinglos, M. N. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.2047 · Cited by 108
Protein and amino acid metabolism after injury
Wolfe, R. R., Jahoor, F., & Hartl, W. H. (1989) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610050205 · Cited by 100
Role of coffee in modulation of diabetes risk
Natella, F., & Scaccini, C. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2012.00470.x · Cited by 103
Cipolletta, E., Campanile, A., Santulli, G., Sanzari, E., Leosco, D., Campiglia, P., Trimarco, B., & Iaccarino, G. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp252 · Cited by 95
Hyperglucagonemia and insulin-mediated glucose metabolism.
Prato, S. D., Castellino, P., Simonson, D. C., & DeFronzo, R. A. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112846 · Cited by 91
Self-citationYki‐Järvinen, H., & Koivisto, V. A. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-3-371 · Cited by 91
Adrenergic signaling and oxidative stress: a role for sirtuins?
Corbi, G., Conti, V., Russomanno, G., Longobardi, G., Furgi, G., Filippelli, A., & Ferrara, N. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00324 · Cited by 93
Metadata
- Authors
- Deibert, D. C., & Defronzo, R. A.
- Affiliations
- Yale University (US)
- ORCID
- Defronzo, Ralph A.
- Venue
- Journal of Clinical Investigation
- Published
- 1980-03-01
- Volume
- 65
- Issue
- 3
- Pages
- 717-721
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC371414
- OpenAlex
- W2064971980
- Cited by
- 557
- References
- 21
- Citations by year
- 2026: 12 · 2025: 5 · 2024: 9 · 2023: 9 · 2022: 5 · 2021: 8 · 2020: 14 · 2019: 10 · 2018: 9 · 2017: 10 · 2016: 10 · 2015: 16 · 2014: 21 · 2013: 10 · 2012: 18
- FWCI
- 11.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- epinephrine, insulin resistance, beta-adrenergic receptors, propranolol, hepatic glucose production, glucose metabolism, insulin secretion, hyperinsulinemic-euglycemic clamp, peripheral insulin sensitivity, stress hyperglycemia
- MeSH terms
- Adult, Amino Acids, Blood Glucose, Drug Resistance, Epinephrine, Female, Glucagon, Glucose, Humans, Insulin, Liver, Male, Propranolol, Receptors, Adrenergic, beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.